Edition:
United Kingdom

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

14.33USD
23 Feb 2018
Change (% chg)

$0.46 (+3.32%)
Prev Close
$13.87
Open
$13.92
Day's High
$14.34
Day's Low
$13.80
Volume
140,356
Avg. Vol
272,497
52-wk High
$28.49
52-wk Low
$11.12

Chart for

About

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The... (more)

Overall

Beta: 3.11
Market Cap(Mil.): $444.74
Shares Outstanding(Mil.): 32.58
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Cara Therapeutics Inc reports Q3 loss per share $0.38

* Cara Therapeutics Inc reports third quarter 2017 financial results

02 Nov 2017

Earnings vs. Estimates